Overview
- 20 FDA inspections are on record.
- 8 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-12-12.
At a glance
Inspections
20
Form 483s
8
EIRs
1
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 3 Dec 2025 – 12 Dec 2025 | Human Drugs | 483 | View 483 → |
| 10 Dec 2024 – 18 Dec 2024 | Biologics | 483 | View 483 → |
| 25 Oct 2022 – 1 Nov 2022 | Medical Devices & Rad Health | 483 | View 483 → |
| 4 Sep 2019 – 11 Sep 2019 | Biologics | 483 | View 483 → |
| 15 Nov 2017 – 22 Nov 2017 | Biologics | 483 | On file |
| 7 Jun 2017 – 15 Jun 2017 | Medical Devices & Rad Health | 483 | View 483 → |
| 18 Aug 2015 – 27 Aug 2015 | Biologics | 483 | On file |
| 11 Mar 2014 – 12 Mar 2014 | Medical Devices & Rad Health | Clean | |
| 5 Nov 2013 – 15 Nov 2013 | Human Drugs | WL | |
| 15 Feb 2012 | Not recorded | Clean | |
| 7 Dec 2011 | Not recorded | Clean | |
| 29 Jun 2010 | Not recorded | Clean | |
Observations on record
Form 483 observations cited at this site, most recent first.
12 Dec 2025
21 CFR 211.113(a)
Procedures for non-sterile drug products
Cited by Santos E Camara, Samantha E Cleek, Mabany Lizardi
12 Dec 2025
21 CFR 211.22(d)
Procedures not in writing, fully followed
Cited by Santos E Camara, Samantha E Cleek, Mabany Lizardi
18 Dec 2024
21 CFR 211.22(d)
Procedures not in writing, fully followed
Cited by Peng Zhou, Laurel A Beer
Investigators
FDA investigators tied to this site in the record.
Edward Deberry4 insp.
Burnell M Henry3 insp.
Cynthia Jim2 insp.
Santos E Camara1 insp.
Samantha E Cleek1 insp.
Mabany Lizardi1 insp.
Peng Zhou1 insp.
Laurel A Beer1 insp.
Christopher B May1 insp.
Gamal A Norton1 insp.
Jacqueline M Diaz Albert1 insp.
Mihaly S Ligmond1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 820.100(a) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 820.22 | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 820.120(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 820.181 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 820.184 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 820.75(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 820.80(d) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 111.120(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 123.8(a)(3)(ii) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.100(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.110(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.113(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c)(10) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c)(10)(iv) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.58 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.67(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 806.10(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.100(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.20(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.30(g) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.50(a)(3) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Greer Laboratories, Inc.'s 8 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat